Premium
Epidermal growth factor receptor ( EGFR ) inhibitory monoclonal antibodies and EGFR tyrosine kinase inhibitors have distinct effects on the keratinocyte innate immune response
Author(s) -
Ommori R.,
Park K.,
Miyagawa F.,
Azukizawa H.,
Kanno M.,
Asada H.
Publication year - 2018
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.15445
Subject(s) - epidermal growth factor receptor , monoclonal antibody , tyrosine kinase , paronychia , cancer research , egfr inhibitors , medicine , gefitinib , immunology , antibody , receptor , dermatology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom